FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

VERIGENE CYP2C19 NUCLEIC ACID TES (2C19)

K Number: K120466 · Decision Nov 6, 2012
Classifications
1
FEI Numbers
3
Registration Numbers
3
Same Product Code
10
Applicant Total
16
Review Days
265

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
VERIGENE CYP2C19 NUCLEIC ACID TES (2C19)
K Number
K120466
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.3360
Medical Specialty
Clinical Toxicology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Nanosphere, Inc.
Date Received
February 15, 2012
Decision Date
November 6, 2012
Product Code
NTI
Advisory Committee
Clinical Toxicology
Review Advisory Committee
TX
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NTI Drug Metabolizing Enzyme Genotyping Systems

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (NTI), ordered by most recent decision date.

View all

Other Clearances by Nanosphere, Inc.

K Number Device Name
K143653 Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex)
K140083 VERIGENE ENTERIC PATHOGEN NUCLEIC ACID TEST ( EP)
K132843 VERIGENE GRAM NEGATIVE BLOOD CULTURE NUCLEIC ACID TEST (BC-GN)
K123197 VERIGENE C. DIFFICILE NUCLEIC ACID TEST (CDF)
K122514 VERIGENE GRAM-POSITIVE BLOOD CULTURE (GC-GP) NUCLEIC ACID TEST
DEN120014 VERIGENE GRAM POSITIVE BLOOD CULTURE NUCLEIC ACID TEST (BC-GP)
K112424 VERIGENE STAPHYLOCOCCUS BLOOD CULTURE NUCLEIC ACID TEST (BC-S)
K103209 VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST +(RVNAT+)
K093337 VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST ON THE VERIGENE SP SYSTEM
K092957 VERIGENE SYSTEM, VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TEST
Search all 16 clearances from Nanosphere, Inc. →